DrugPatentWatch Database Preview
RIASTAP Drug Profile
Email this page to a colleague
» See Plans and PricingSummary for Tradename: RIASTAP
| Patents: | 41 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for RIASTAP |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for RIASTAP |
Recent Clinical Trials for RIASTAP
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Emory University | Phase 3 |
| Australian Red Cross | Phase 2 |
| Gold Coast Hospital and Health Service | Phase 2 |
Recent Litigation for RIASTAP
Identify key patents and potential future biosimilar entrants
PTAB Litigation
| Petitioner | Date |
|---|---|
| 2014-11-04 |
Patent Text Search: US Patents for RIASTAP
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. (Rockville, MD) Virginia Commonwealth University (Richmond, VA) | 2028-04-11 | search | ||
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | JAPAN BLOOD PRODUCTS ORGANIZATION (Tokyo, JP) | 2033-12-27 | search | ||
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | Universite Paris Descartes (Paris, FR) Assistance Publique--Hopitaux De Paris (Paris, FR) Universite Paris--Sud (Orsay, FR) Universite Pierre et Marie Curie (Paris 6) (Paris, FR) Institut National De La Sante et De La Recherche Medical | 2035-03-20 | search | ||
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | The Radiochemical Centre Limited (Amersham, EN) | 1993-01-20 | search | ||
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | 1995-05-15 | search | |||
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | American Home Products Corporation (New York, NY) | 1995-10-31 | search | ||
| Csl Behring Gmbh | RIASTAP | fibrinogen human | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 125317 | 1 | 2009-01-16 | Start Trial | American Home Products Corp. (Del.) (New York, NY) | 1995-10-31 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for RIASTAP
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016150926 | Start Trial |
| United Kingdom | 1534956 | Start Trial |
| Germany | 102007026153 | Start Trial |
| Germany | 3486030 | Start Trial |
| World Intellectual Property Organization (WIPO) | 02064750 | Start Trial |
| Portugal | 878195 | Start Trial |
| Portugal | 1343542 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
